Watchlist Price Alert

Cytek Biosciences Inc. (CTKB)

NASDAQ: CTKB · Real-Time Price · USD

3.23

-0.07 (-2.12%)

At close: Jun 17, 2025, 11:25 AM

Cytek Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-6.02M	-12.15M	2.48M	3.03M	19.41M	-16.83M
Depreciation & Amortization	10.49M	9.23M	5.66M	1.24M	603K	309K
Stock-Based Compensation	26.85M	22.05M	16.59M	6.59M	611K	269K
Other Working Capital	n/a	-5.68M	-4.39M	11.04M	-2.11M	27.17M
Other Non-Cash Items	-10.77M	-3.34M	2.96M	1.97M	323K	1.34M
Deferred Income Tax	-2.89M	n/a	n/a	448K	1.74M	n/a
Change in Working Capital	n/a	-10.51M	-39.93M	-8.65M	-7.54M	1.16M
Operating Cash Flow	25.38M	5.28M	-12.23M	4.63M	15.16M	-13.75M
Capital Expenditures	-3.52M	-4.83M	-9.87M	-4.36M	-1.55M	-973K
Cash Acquisitions	-471K	-45.13M	n/a	-16.63M	n/a	n/a
Purchase of Investments	-274.06M	-175.94M	-46.04M	n/a	n/a	n/a
Sales Maturities Of Investments	195M	132M	n/a	n/a	n/a	n/a
Other Investing Acitivies	84K	-179K	-46.16M	371K	n/a	n/a
Investing Cash Flow	-82.97M	-93.89M	-55.91M	-20.99M	-1.55M	-973K
Debt Repayment	3.62M	-565K	2.93M	n/a	2.77M	n/a
Common Stock Repurchased	-21.61M	-44.15M	-209K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.17M	2.9M	2.58M	213.56M	119.83M	93K
Financial Cash Flow	-15.82M	-41.81M	5.51M	213.56M	122.61M	93K
Net Cash Flow	-68.89M	-131.87M	-65.12M	198.5M	135.63M	-14.66M
Free Cash Flow	21.85M	454K	-22.1M	266K	13.61M	-14.72M